Mixed Results for Thrombolysis in Pulmonary Embolism
The role of thrombolytic therapy for the treatment of pulmonary embolism has been unclear, as it has been difficult to measure the precise balance between enhanced clot-dissolving efficacy and greater bleeding risk produced by thrombolysis when compared with conventional anticoagulation.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Larry Husten Source Type: news
More News: Bleeding | Pharmaceuticals | Pulmonary Thromboembolism | Thrombolytic Therapy | Thrombosis